Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 2, 2012, Pages 369-375

  Nakamura, Akira ^a   Shibuya, Keiko ^a   Matsuo, Yukinori ^a   Nakamura, Mitsuhiro ^a   Shiinoki, Takehiro ^a   Mizowaki, Takashi ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Acute gastrointestinal toxicity; Dose toxicity relationship; Gemcitabine based chemoradiotherapy; Pancreatic cancer; Upper gastrointestinal bleeding

Indexed keywords

ADVERSE EVENTS; CONCURRENT CHEMORADIOTHERAPY; DOSE-TOXICITY RELATIONSHIP; DOSIMETRIC PARAMETER; GASTROINTESTINAL TOXICITIES; GEMCITABINE; INTENSITY-MODULATED RADIOTHERAPY; MEAN DOSE; NOVEL TECHNIQUES; PANCREATIC CANCERS; PLANNING TARGET VOLUMES; PREDICTIVE FACTORS; SMALL INTESTINE; UNIVARIATE ANALYSIS; UPPER GASTROINTESTINAL;

CHEMORADIOTHERAPY; DIGESTIVE SYSTEM; DISEASES; DOSIMETERS; DOSIMETRY; DRUG PRODUCTS; FACTOR ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; THREE DIMENSIONAL;

TOXICITY;

GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSIMETRY; DUODENUM; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; MALE; MUCOSA INFLAMMATION; NAUSEA; PANCREAS CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SMALL INTESTINE; STOMACH; UPPER GASTROINTESTINAL BLEEDING; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DOSE FRACTIONATION; DUODENUM; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; ORGANS AT RISK; PANCREATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; STOMACH; TUMOR BURDEN;

EID: 84865627118     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.026     Document Type: Article

References (13)

1. N. Oya, K. Shibuya, and T. Sakamoto Chemoradiotherapy in patients with pancreatic carcinoma: Phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine Pancreatology 6 2006 109 116
2. K. Shibuya, N. Oya, and T. Fujii Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer Am J Clin Oncol 34 2011 115 119
3. C.G. Moertel, S. Frytak, and R.G. Hahn Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
4. M.S. Talamonti, P.J. Catalano, and D.J. Vaughn Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity J Clin Oncol 18 2000 3384 3389
5. C.H. Crane, J.L. Abbruzzese, and D.B. Evans Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 2002 1293 1302
6. J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808
7. B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S101 S107
8. T.M. Therneau, P.M. Grambsch, and T.R. Fleming Martingale-based residuals for survival models Biometrika 77 1990 147 160
9. H.M. Ceha, G. van Tienhoven, and D.J. Gouma Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma Cancer 89 2000 2222 2229
10. T.M. Therneau, and P.M. Grambsch Modeling survival data: Extending the Cox model 2000 Springer New York
11. T. Okusaka, Y. Ito, and H. Ueno Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Br J Cancer 91 2004 673 677
12. Y. Ito, T. Okusaka, and Y. Kagami Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer Anticancer Res 26 Suppl. 5B 2006 3755 3759
13. J.D. Murphy, C. Christman-Skieller, and J. Kim A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 1420 1426